Posts

BGB-30813 by BeiGene for Head And Neck Squamous Cell Ca...

BGB-30813 is under clinical development by BeiGene and currently in Phase I for ...

NT-175 by Neogene Therapeutics for Head And Neck Squamo...

NT-175 is under clinical development by Neogene Therapeutics and currently in Ph...

ORB-011 by Orionis Biosciences for Head And Neck Squamo...

ORB-011 is under clinical development by Orionis Biosciences and currently in Ph...

ODM-212 by Orion for Solid Tumor: Likelihood of Approval

ODM-212 is under clinical development by Orion and currently in Phase I for Soli...

KB-707 by Krystal Biotech for Solid Tumor: Likelihood o...

KB-707 is under clinical development by Krystal Biotech and currently in Phase I...

RO-7566802 by Genentech USA for Solid Tumor: Likelihood...

RO-7566802 is under clinical development by Genentech USA and currently in Phase...

AWT-020 by Anwita Biosciences for Sarcomas: Likelihood ...

AWT-020 is under clinical development by Anwita Biosciences and currently in Pha...

STAT+: The clock is ticking, and Cytokinetics is runnin...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Health data breaches hit an all-time high in 2023

At least 116 million individuals were impacted by large and numerous health data...

STAT+: BioMarin appeases an activist

Want to stay on top of the science and politics driving biotech today? Sign up t...

Unraveling the mystery of hereditary diffuse gastric ca...

Gastric cancer, a significant global health burden, claims over 7% of cancer-rel...

Electronic “soil” enhances crop growth

Barley seedlings grow on average 50% more when their root system is stimulated e...

Devimistat by Cornerstone Pharmaceuticals for Soft Tiss...

Devimistat is under clinical development by Cornerstone Pharmaceuticals and curr...

(Nanatinostat + valganciclovir) by Viracta Therapeutics...

(Nanatinostat + valganciclovir) is under clinical development by Viracta Therape...

Enzalutamide by Pfizer for Fallopian Tube Cancer: Likel...

Enzalutamide is under clinical development by Pfizer and currently in Phase II f...

(Curcumin + doxorubicin) by Immix BioPharma for Colorec...

(Curcumin + doxorubicin) is under clinical development by Immix BioPharma and cu...